Table 2.
Correlation of histomorphological parameters and cellular dissociation grade with clinicopathological data.
| Cell Nest Size | Budding activity | Grading | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large | Intermediate | Small | Single-cell invasion | p-value | Absent | Low | High | p-value | nG1 | nG2 | nG3 | p-value | |
| Age | |||||||||||||
| Median and below | 6 | 11 | 28 | 35 | 0.589 | 17 | 43 | 20 | 0.927 | 17 | 44 | 19 | 0.981 |
| Above median | 10 | 7 | 27 | 36 | 17 | 45 | 18 | 17 | 45 | 18 | |||
| Gender | |||||||||||||
| Male | 13 | 18 | 41 | 57 | 0.131 | 31 | 66 | 32 | 0.104 | 31 | 67 | 31 | 0.117 |
| Female | 3 | 0 | 14 | 14 | 3 | 22 | 6 | 3 | 22 | 6 | |||
| cT stage | |||||||||||||
| 1 | 3 | 1 | 11 | 1 | 0.017 | 4 | 11 | 1 | 0.059 | 4 | 11 | 1 | 0.100 |
| 2 | 3 | 5 | 12 | 12 | 8 | 21 | 3 | 8 | 21 | 3 | |||
| 3 | 3 | 2 | 6 | 12 | 5 | 9 | 9 | 5 | 10 | 8 | |||
| 4a/b | 1 | 3 | 6 | 19 | 4 | 15 | 10 | 4 | 15 | 10 | |||
| cN stage | |||||||||||||
| 0 | 4 | 6 | 18 | 12 | 0.010 | 10 | 23 | 7 | 0.447 | 10 | 23 | 7 | 0.404 |
| 1 | 1 | 4 | 6 | 4 | 5 | 7 | 3 | 5 | 8 | 2 | |||
| 2 | 5 | 1 | 9 | 28 | 6 | 24 | 13 | 6 | 24 | 13 | |||
| 3 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | |||
| Pre-therapeutic UICC stage | |||||||||||||
| I | 2 | 1 | 8 | 0 | 0.073 | 3 | 8 | 0 | 0.142 | 3 | 8 | 0 | 0.231 |
| II | 1 | 3 | 6 | 5 | 4 | 10 | 1 | 4 | 10 | 1 | |||
| II | 2 | 3 | 7 | 9 | 5 | 8 | 8 | 5 | 9 | 7 | |||
| Iva/b | 5 | 4 | 14 | 30 | 9 | 30 | 14 | 9 | 30 | 14 | |||
| pT stage | |||||||||||||
| 1 | 7 | 4 | 19 | 7 | 0.001 | 11 | 23 | 3 | 0.002 | 11 | 23 | 3 | 0.002 |
| 2 | 2 | 8 | 18 | 24 | 10 | 32 | 10 | 10 | 33 | 9 | |||
| 3 | 6 | 4 | 3 | 19 | 10 | 9 | 13 | 10 | 9 | 13 | |||
| 4a/b | 1 | 2 | 15 | 21 | 3 | 24 | 12 | 3 | 24 | 12 | |||
| pN stage | |||||||||||||
| 0 | 12 | 12 | 31 | 18 | <0.001 | 24 | 39 | 10 | 0.001 | 24 | 39 | 10 | 0.001 |
| 1 | 2 | 2 | 9 | 13 | 4 | 16 | 6 | 4 | 17 | 5 | |||
| 2 | 2 | 4 | 14 | 40 | 6 | 32 | 22 | 6 | 32 | 22 | |||
| 3 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | |||
| Post-therapeutic UICC stage | |||||||||||||
| I | 7 | 3 | 15 | 3 | 0.001 | 10 | 16 | 2 | 0.003 | 10 | 16 | 2 | 0.005 |
| II | 1 | 4 | 5 | 6 | 5 | 11 | 0 | 5 | 11 | 0 | |||
| II | 5 | 5 | 9 | 17 | 10 | 15 | 11 | 10 | 16 | 10 | |||
| Iva/b | 3 | 6 | 26 | 45 | 9 | 46 | 25 | 9 | 46 | 25 | |||
| Recurrence | |||||||||||||
| No recurrence | 14 | 16 | 28 | 36 | 0.248 | 30 | 47 | 17 | 0.321 | 30 | 47 | 17 | 0.394 |
| Local recurrence | 1 | 2 | 11 | 8 | 3 | 14 | 5 | 3 | 14 | 5 | |||
| Nodale recurrence | 0 | 0 | 5 | 1 | 0 | 6 | 0 | 0 | 6 | 0 | |||
| Distant recurrence | 1 | 0 | 4 | 15 | 1 | 11 | 8 | 1 | 11 | 8 | |||
| Combined recurrence | 0 | 0 | 6 | 9 | 0 | 8 | 7 | 0 | 9 | 6 | |||
| Recurrence; localisation unclear | 0 | 0 | 1 | 2 | 0 | 2 | 1 | 0 | 2 | 1 | |||
The values given in italics are the p-values obtained in statistical analysis for the respective correlations